The Phototherapy Equipment Market is estimated to be valued at USD 716.5 million in 2025 and is projected to reach USD 1259.1 million by 2035, registering a compound annual growth rate (CAGR) of 5.8% over the forecast period.
| Metric | Value |
|---|---|
| Phototherapy Equipment Market Estimated Value in (2025 E) | USD 716.5 million |
| Phototherapy Equipment Market Forecast Value in (2035 F) | USD 1259.1 million |
| Forecast CAGR (2025 to 2035) | 5.8% |
The phototherapy equipment market is witnessing significant expansion, primarily supported by the increasing incidence of neonatal jaundice, skin-related disorders, and growing awareness about advanced light-based therapies. The rising adoption of energy-efficient lighting technologies such as LEDs, coupled with the demand for non-invasive treatment options, is driving market growth across both developed and emerging regions. Advancements in device design, portability, and energy efficiency are enhancing patient comfort and improving treatment outcomes, further strengthening adoption in hospitals and specialty clinics.
Governments and healthcare institutions are placing strong emphasis on reducing infant mortality rates and improving neonatal care infrastructure, which is encouraging the use of phototherapy equipment. Increasing healthcare spending, coupled with technological improvements in treatment precision and safety, is also shaping future demand.
As global healthcare systems focus more on preventive and early-stage treatment, phototherapy is expected to gain greater prominence The market outlook remains positive as manufacturers continue investing in innovation, such as portable and home-based systems, while also expanding access in regions with growing healthcare infrastructure needs.
The phototherapy equipment market is segmented by product, application, end user, and geographic regions. By product, phototherapy equipment market is divided into LED-based, Fiber Optic, Conventional, and Others. In terms of application, phototherapy equipment market is classified into Neonatal Jaundice Management, Skin Disease Treatment, Psoriasis, Vitiligo, Eczema, and Others. Based on end user, phototherapy equipment market is segmented into Hospitals, Dermatology Clinics, and Homecare Settings. Regionally, the phototherapy equipment industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The LED-based product segment is projected to account for 36.9% of the phototherapy equipment market revenue share in 2025, making it the leading product category. Its dominance is being driven by the superior efficiency, longer lifespan, and lower energy consumption offered by LED technology compared to conventional light sources. LED-based devices provide consistent light intensity with minimal heat generation, ensuring improved safety and comfort for patients, particularly neonates.
These products are also easier to maintain due to their durability and lower replacement requirements, reducing the overall operational costs for healthcare providers. The ability to customize wavelength output for targeted therapies enhances clinical effectiveness, thereby reinforcing their widespread adoption in both hospitals and specialized clinics.
Technological advancements are enabling compact and portable LED-based systems, further expanding their applications in neonatal intensive care units and home care settings As healthcare facilities increasingly prioritize sustainability and cost efficiency, LED-based phototherapy devices are expected to maintain their leadership position and continue driving market growth globally.
The neonatal jaundice management segment is anticipated to represent 29.7% of the phototherapy equipment market revenue share in 2025, positioning it as the largest application area. This leadership is being reinforced by the high prevalence of neonatal hyperbilirubinemia, a common condition requiring immediate intervention to prevent complications. Phototherapy has been established as the primary treatment method due to its non-invasive nature and proven effectiveness in reducing bilirubin levels.
Growing global initiatives aimed at lowering infant morbidity and mortality are increasing the adoption of advanced phototherapy devices in neonatal intensive care units and maternity wards. The segment is further benefiting from the availability of portable and user-friendly devices that allow for flexible use across different healthcare settings.
Rising awareness among healthcare professionals and parents about the importance of early treatment of jaundice is also contributing to greater demand With continuous advancements in light-based treatment technologies, the neonatal jaundice management segment is expected to maintain its leadership and remain a primary driver of growth for the overall market.
The hospitals segment is expected to hold 50.9% of the phototherapy equipment market revenue share in 2025, making it the leading end user category. Its dominance is being explained by the comprehensive infrastructure hospitals provide, enabling them to integrate advanced phototherapy devices into both neonatal and dermatological care. Hospitals are often the first point of care for infants born with jaundice or patients suffering from skin conditions, ensuring high demand for these devices within their facilities.
The availability of trained medical professionals, along with robust neonatal intensive care units and maternity wards, enhances the adoption of advanced phototherapy systems. Increasing investments in hospital infrastructure, particularly in developing economies, are further strengthening this segment’s growth.
Additionally, hospitals are benefiting from government and non-governmental programs that aim to improve neonatal health outcomes by expanding access to phototherapy treatment The preference for hospital-based treatment, due to higher reliability and safety, reinforces the leadership of this end user category, making it a key growth driver for the market moving forward.
The rise in low-weight births and premature as well as the prevalence of severe skin conditions like rosacea, eczema, acne and hives which has led to an increase in treatment options to reduce infant jaundice mortality rates are driving the rapid growth of the global phototherapy market. Additionally, it is anticipated that the increasing use of LED-based phototherapy equipment will accelerate the growth of the phototherapy market.
It is projected that increased patient awareness of advanced treatment choices and better healthcare infrastructure will fuel market expansion. The availability of phototherapy equipment for home use is also anticipated to increase demand among people with skin conditions.
Neonatal jaundice can also be treated with phototherapy. The newborns receive this treatment where they are exposed to fluorescent light, which speeds up their recovery. Due to all these factors, the demand for the phototherapy equipment market is increasing.
A significant portion of the phototherapy equipment market share is expected to be hold by North America, which will exhibit a sharp increase in the annual growth rate. This can be largely due to the rise in neonatal jaundice cases and other skin-related conditions.
Furthermore, during the projected period, it is anticipated that better healthcare infrastructure and increasing public awareness of modern treatment options will enhance the market for phototherapy equipment in this region.
The increasing popularity of medical tourism in the region, the government increasing support for healthcare initiatives and the expansion of major regional market players as well as the availability of inexpensive phototherapy equipment in China and India contribute to the East and South Asia region expect strong growth.
Some of the key market players present in the phototherapy equipment industry are GE Healthcare, Aeroflow Healthcare, The Daavlin Company, Philips Lighting Holding B.V., Hill-Rom, Herbert Waldmann GmbH & Co. KG, Solarc Systems Inc., Medela AG, National Biological Corp., Natus Medical Incorporated and Phoenix Medical Systems Pvt. Ltd.
| Country | CAGR |
|---|---|
| China | 7.8% |
| India | 7.3% |
| Germany | 6.7% |
| France | 6.1% |
| UK | 5.5% |
| USA | 4.9% |
| Brazil | 4.4% |
The Phototherapy Equipment Market is expected to register a CAGR of 5.8% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 7.8%, followed by India at 7.3%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 4.4%, yet still underscores a broadly positive trajectory for the global Phototherapy Equipment Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 6.7%. The USA Phototherapy Equipment Market is estimated to be valued at USD 251.7 million in 2025 and is anticipated to reach a valuation of USD 407.3 million by 2035. Sales are projected to rise at a CAGR of 4.9% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 33.1 million and USD 24.3 million respectively in 2025.
| Item | Value |
|---|---|
| Quantitative Units | USD 716.5 Million |
| Product | LED-based, Fiber Optic, Conventional, and Others |
| Application | Neonatal Jaundice Management, Skin Disease Treatment, Psoriasis, Vitiligo, Eczema, and Others |
| End User | Hospitals, Dermatology Clinics, and Homecare Settings |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
| Key Companies Profiled | GE Healthcare, Philips Lighting Holding B.V., Natus Medical Incorporated, Hill-Rom, The Daavlin Company, Herbert Waldmann GmbH & Co. KG, Medela AG, Solarc Systems Inc., National Biological Corp., Aeroflow Healthcare, and Phoenix Medical Systems Pvt. Ltd. |
The global phototherapy equipment market is estimated to be valued at USD 716.5 million in 2025.
The market size for the phototherapy equipment market is projected to reach USD 1,259.1 million by 2035.
The phototherapy equipment market is expected to grow at a 5.8% CAGR between 2025 and 2035.
The key product types in phototherapy equipment market are led-based, fiber optic, conventional and others.
In terms of application, neonatal jaundice management segment to command 29.7% share in the phototherapy equipment market in 2025.
Explore Similar Insights
Phototherapy Equipment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
